IXICO plc (AIM:IXI)
London · Delayed Price · Currency is GBP · Price in GBX 8.10
-0.40 (-4.71%)
Jul 24, 2026, 3:30 PM GMT
IXICO Market Cap
IXICO has a market cap or net worth of 18.53 million as of July 24, 2026. Its market cap has increased by 90.48% in one year.
Market Cap
18.53M
Enterprise Value
17.42M
Revenue
7.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.10
ChartMarket Cap Chart
Since October 15, 2013, IXICO's market cap has increased from 8.82M to 18.53M, an increase of 110.09%. That is a compound annual growth rate of 5.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 18.53M | 70.22% |
| Dec 31, 2025 | 10.89M | - |
| Dec 31, 2024 | 10.89M | 80.16% |
| Dec 29, 2023 | 6.04M | -50.98% |
| Dec 30, 2022 | 12.33M | -57.32% |
| Dec 31, 2021 | 28.89M | -40.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hemogenyx Pharmaceuticals | 49.44M |
| Poolbeg Pharma | 46.95M |
| Sareum Holdings | 30.48M |
| SkinBioTherapeutics | 30.45M |
| ImmuPharma | 24.96M |
| Arecor Therapeutics | 23.98M |
| Aptamer Group | 16.41M |
| Fusion Antibodies | 13.44M |